期刊: JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2022; 20 (12)
Background Thrombosis and hemorrhage as two opposite pathologies are prevalent within the chronic kidney disease (CKD) population. Platelet homeostasi......
期刊: JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2022; 20 (3)
Background Vascular injury initiates rapid platelet activation, which is critical for haemostasis, while it also causes fatal thrombotic diseases, suc......
期刊: JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2022; 20 (12)
Background and Objectives: Platelets are affected by many factors, such as infectious or aseptic inflammation, and different inflammatory states may i......
期刊: JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2022; 20 (9)
Vitamin K antagonists (VKAs), such as warfarin, are oral anticoagulants widely used to treat and prevent thromboembolic diseases. Therapeutic use of t......
期刊: JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2022; 20 (3)
Background The efficacy of hetrombopag in Chinese patients with immune thrombocytopenia (ITP) has been demonstrated in a randomized, double-blind, pla......
期刊: JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2022; 20 (8)
Background The production of platelets is tightly regulated by thrombopoietin (THPO). Mutations in the THPO gene cause thrombocytopenia. Although mice......
期刊: JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2022; 20 (1)
Background Tissue dynamics of von Willebrand factor (VWF) that are vital to its biological function have not been fully characterized. Objective To de......
期刊: JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2021; 19 (7)
Background Pulmonary embolism (PE) is a leading cause of cardiovascular mortality worldwide. Rapid and accurate diagnosis and risk stratification are ......
期刊: JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2021; 19 (8)
Background Chemotherapy-induced thrombocytopenia (CIT) can increase the risk of bleeding, which may delay or prevent the administration of anticancer ......